US20050098241A1 - Niobium-Zirconium Alloy for medical devices or their parts - Google Patents
Niobium-Zirconium Alloy for medical devices or their parts Download PDFInfo
- Publication number
- US20050098241A1 US20050098241A1 US10/705,566 US70556603A US2005098241A1 US 20050098241 A1 US20050098241 A1 US 20050098241A1 US 70556603 A US70556603 A US 70556603A US 2005098241 A1 US2005098241 A1 US 2005098241A1
- Authority
- US
- United States
- Prior art keywords
- medical implant
- metal alloy
- weight percent
- medical
- implant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229910001093 Zr alloy Inorganic materials 0.000 title description 2
- GFUGMBIZUXZOAF-UHFFFAOYSA-N niobium zirconium Chemical compound [Zr].[Nb] GFUGMBIZUXZOAF-UHFFFAOYSA-N 0.000 title description 2
- 239000007943 implant Substances 0.000 claims abstract description 37
- 239000010955 niobium Substances 0.000 claims abstract description 18
- 229910052758 niobium Inorganic materials 0.000 claims abstract description 17
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229910052726 zirconium Inorganic materials 0.000 claims abstract description 17
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229910001092 metal group alloy Inorganic materials 0.000 claims abstract description 14
- 229910052751 metal Inorganic materials 0.000 claims description 8
- 239000002184 metal Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 150000002739 metals Chemical class 0.000 claims description 5
- 239000003102 growth factor Substances 0.000 claims description 4
- 210000003709 heart valve Anatomy 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 3
- 230000000975 bioactive effect Effects 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 235000014633 carbohydrates Nutrition 0.000 claims description 3
- 239000000919 ceramic Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000003527 fibrinolytic agent Substances 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 210000000130 stem cell Anatomy 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- HTXDPTMKBJXEOW-UHFFFAOYSA-N dioxoiridium Chemical compound O=[Ir]=O HTXDPTMKBJXEOW-UHFFFAOYSA-N 0.000 claims 1
- 229910000457 iridium oxide Inorganic materials 0.000 claims 1
- 238000007740 vapor deposition Methods 0.000 claims 1
- 239000000463 material Substances 0.000 description 19
- 229910045601 alloy Inorganic materials 0.000 description 18
- 239000000956 alloy Substances 0.000 description 18
- 238000002595 magnetic resonance imaging Methods 0.000 description 11
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 10
- 239000010936 titanium Substances 0.000 description 10
- 229910052719 titanium Inorganic materials 0.000 description 10
- 238000000034 method Methods 0.000 description 7
- 229910001069 Ti alloy Inorganic materials 0.000 description 5
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 238000005260 corrosion Methods 0.000 description 4
- 230000007797 corrosion Effects 0.000 description 4
- 229910052750 molybdenum Inorganic materials 0.000 description 4
- 239000011733 molybdenum Substances 0.000 description 4
- 229910052715 tantalum Inorganic materials 0.000 description 4
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 4
- 238000000576 coating method Methods 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 229910020018 Nb Zr Inorganic materials 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 229910001040 Beta-titanium Inorganic materials 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229910001182 Mo alloy Inorganic materials 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- DKPSLNRKGICERV-UHFFFAOYSA-N [Zr].[Ti].[Nb].[Mo] Chemical compound [Zr].[Ti].[Nb].[Mo] DKPSLNRKGICERV-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000010292 electrical insulation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 238000005488 sandblasting Methods 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004865 vascular response Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/02—Inorganic materials
Definitions
- the present invention relates to a Niobium-Zirconium Alloy for medical implants or devices to be inserted into the human body for a prolonged period of time.
- a medical implant or device must satisfy a number of requirements. When the material for manufacturing these devices is chosen, factors like biocompatibility and a range of mechanical properties have to be considered. The material must not cause any inflammatory reaction or allergic reaction. Commonly used materials often include nickel, like medical grade 316L stainless steel, which contains about 16% nickel. For patients with an allergic reaction the implantation of such materials is contraindicated. Another consideration in material selection is the need for the implanting physician to be able to visualize the position of the medical implant or device during procedure to the desired target site in the body, and for purposes of examination from time to time thereafter at the implant site, typically by X-ray fluoroscopy.
- MRI compatibility is desirable.
- the metal alloys commonly used for implantation like stainless steel 316
- alloys like Nitinol behave more favourably in MRI, their MRI compatibility is not considered to be sufficiently good.
- This invention relates to medical devices or implants in general such as catheters, guide wires, stents, stent grafts and heart valve repair devices.
- Stents are generally thin walled tubular-shaped devices composed of complex patterns of interconnecting struts which function to hold open a segment of a blood vessel or other body lumen like oesophagus and urethra.
- Stent grafts are stents with a circumferential covering or lining and are suitable for supporting a dissected artery or intimal flap that can occlude a vessel lumen.
- Stents and stent grafts are typically implanted by use of a catheter. Initially they are maintained in a radially compressed state to manoeuvre them through the lumen. Once in position, they are deployed.
- the material from which the vascular prosthesis like stents or stent grafts is constructed must allow the prosthesis to undergo expansion, which typically requires substantial deformation. Once expanded the stent must maintain its size and shape and must be capable of withstanding the structural loads, namely radial compressive forces, imposed on the stent as it supports the walls of a vessel lumen.
- the wall of the prosthesis must be sufficiently thick, depending on the stent material, not only to withstand the vessel wall recoil but also allow the stent to be seen on the fluoroscope.
- the prosthesis material must be biocompatible so as not to trigger any adverse vascular responses like restenosis or thrombus formation in the treated vessel.
- EP 0 788 802 provides a self-expanding stent consisting of a titanium alloy including at least about 68 weight percent titanium and optionally Niobium, Zirconium, and Molybdenum.
- U.S. Pat. No. 6,238,491 and WO 00/68448 describe a Niobium-Titanium-Zirconium-Molybdenum alloy for medical devices providing a uniform ⁇ -structure, which is corrosion resistant, and can be processes to develop high-strength and low-modulus.
- the alloy comprises 29 to 70 weight percent Niobium, 10 to 46 weight percent Zirconium, 3 to 15 weight percent Molybdenum and a balance of Titanium.
- Davidson employ an alloy consisting essentially of Titanium, 10 to 20 or 25 to 50 weight percent Niobium and optionally up to 20 weight percent Zirconium, the alloy having an elastic modulus less than 90 GPa.
- Similar Titanium-alloys for medical implants also published by Davidson comprise Titanium, 10 to 20 or 35 to 50 weight percent Niobium and optionally up to 20 weight percent each Zirconium and Tantalum (EP 0 437 079) or Titanium, 10 to 20 or 35 to 50 weight percent each Niobium and Tantalum and optionally up to 20 weight percent Zirconium (U.S. Pat. No. 5,690,670).
- EP 0 707 085 also provides a low modulus, biocompatible Titanium-base alloy for medical devices consisting of 20 to 40 weight percent
- a further high strength, low modulus and biocompatible Titanium-alloy is laid open in U.S. Pat. No. 4,857,269 and EP 0 359 446 consisting of Titanium and up to 25 weight percent Niobium, Zirconium, and Molybdenum.
- EP 1 046 722 describes a corrosion resistant Titanium-Zirconium-type alloy for medical appliances consisting of 25 to 50 weight percent Titanium, 5 to 30 weight percent Niobium, 5 to 40 weight percent Tantalum and 25 to 60 weight percent Zirconium.
- the material should fulfil all mechanical and structural requirements according to its function in a medical implant or device. Moreover, the material should be sufficiently radio-opaque to allow for good imaging of the device under x-ray without the addition of an extra layer or portion of radio-opaque material. Also, the material should not overly bright in X-ray imaging and should not obscure the image of the surrounding tissue, as would be the case with a device made from an extremely dense material. In addition, the material should be MRI safe and compatible, preferably also visible under MRI.
- the radio-opacity of the presently claimed Nb-Zr alloy is sufficient to be readily visualized under x-ray during medical procedures and yet is not so radio-opaque as to interfere with the visualization of surrounding body tissue.
- the material is generally an alloy of about 99% of Zr, rest Nb (Nb-1% Zr or NbZr1)—known for long as a reactor tubing material and for various other applications. It can easily be obtained in sheet or tube form. It is especially suitable for stents which require delicate and complicated patterns to be cut from the sheet or tube. The cutting is usually done by laser methods. Stents with low wall thickness may conveniently be manufactured.
- the alloy of the invention can be easily cold-worked to increase strength and reduce elastic modulus. It is possible to form a hard, abrasion resistant surface on the inventive alloy through standard oxidation and nitridizing methods known by those skilled in the art. The presence of a hard, inert, abrasion resistant surface layer presents an important option for medical implants and devices in which it is desirable to have lower friction and wear, electrical insulation and improved corrosion resistance.
- At least a portion of the surface of the inventive alloy can be conversion surface hardened and/or coated.
- coatings can include, but are not limited to a polymer, a blend of polymers, a metal, a blend of metals, a ceramic and/or biomolecules, in particular peptides, proteins, lipids, carbohydrates and/or nucleic acids (e.g. collagen, heparin, fibrin, phosphorylcholine, cellulose, morphogenic proteins or peptides, growth factors).
- alloy surface or the coatings can comprise stem cells and/or a bioactive substances, in particular drugs, antibiotics, growth factors, anti-inflammatory agents and/or anti-thrombogenic agents.
- the surface can be modified by electropolishing or mechanical polishing for formation of a completely smooth surface, sintering to achieve a porous coating as for example described in EP0601804, or by roughening procedures or microblasting, in particular sandblasting, to achieve a rough surface.
- the Nb-Zr alloy is useful in the manufacturing of a variety of medical implants and devices.
- the manufacture of medical devices from the invention alloy includes minimal-invasive devices, in particular guide wires, catheters (balloon catheters, guiding catheter, angiographic catheters, functional catheters), intra-cavernous implants, in particular intra-oesophagus, intra-urethra, intra-tracheal implants and intra-vascular implants, in particular stents, stent grafts, stent graft connector, heart valve repair device or filters.
- the invention relates to medical implants or devices fabricated from the above-mentioned alloys, e.g. minimal-invasive devices, in particular catheters or guide wires, or intra-cavernous implants, in particular intravascular implants, such as stents, stent grafts, stent graft connectors or heart valve repair devices.
- minimal-invasive devices in particular catheters or guide wires
- intra-cavernous implants in particular intravascular implants, such as stents, stent grafts, stent graft connectors or heart valve repair devices.
- the surface of the metal alloys may be passivated by oxidation or nitridization, or may be electropolished, mechanically polished, micro blasted, roughened or sintered, or may be coated with a polymer, a blend of polymers, a metal, a blend of metals, a ceramic and/or biomolecules, in particular peptides, proteins, lipids, carbohydrates and/or nucleic acids; or may be coated with stem cells and/or a bioactive substance, in particular drugs, antibiotics, growth factors, anti-inflammatory agents and/or anti-thrombogenic agents.
- a preferred material for the implants or devices of the invention is the following (All percentages are by weight): 98.85-99.15 weight percent Niobium and 0.85-1.15% Zirconium, preferably 99.05-99.15 weight percent Niobium, and 0.85-0.95% weight percent Zirconium. Especially preferred is the material: 99.05-99.15 weight percent Niobium and 0.85-0.95% weight percent Zirconium.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
A medical implant or device which is at least partially fabricated from a metal alloy consisting essentially of (a) 98.85-99.15 weight percent Niobium, (b) 0.85-1.15% weight percent Zirconium.
Description
- The present invention relates to a Niobium-Zirconium Alloy for medical implants or devices to be inserted into the human body for a prolonged period of time.
- A medical implant or device must satisfy a number of requirements. When the material for manufacturing these devices is chosen, factors like biocompatibility and a range of mechanical properties have to be considered. The material must not cause any inflammatory reaction or allergic reaction. Commonly used materials often include nickel, like medical grade 316L stainless steel, which contains about 16% nickel. For patients with an allergic reaction the implantation of such materials is contraindicated. Another consideration in material selection is the need for the implanting physician to be able to visualize the position of the medical implant or device during procedure to the desired target site in the body, and for purposes of examination from time to time thereafter at the implant site, typically by X-ray fluoroscopy.
- With the growing importance of magnetic resonance imaging (MRI), MRI compatibility is desirable. The metal alloys commonly used for implantation (like stainless steel 316) induce a local disturbance of the magnetic field used in MRI, to the extent that imaging of surrounding tissue is impeded. Although alloys like Nitinol behave more favourably in MRI, their MRI compatibility is not considered to be sufficiently good.
- This invention relates to medical devices or implants in general such as catheters, guide wires, stents, stent grafts and heart valve repair devices.
- Stents are generally thin walled tubular-shaped devices composed of complex patterns of interconnecting struts which function to hold open a segment of a blood vessel or other body lumen like oesophagus and urethra. Stent grafts are stents with a circumferential covering or lining and are suitable for supporting a dissected artery or intimal flap that can occlude a vessel lumen. Stents and stent grafts are typically implanted by use of a catheter. Initially they are maintained in a radially compressed state to manoeuvre them through the lumen. Once in position, they are deployed. The material from which the vascular prosthesis like stents or stent grafts is constructed must allow the prosthesis to undergo expansion, which typically requires substantial deformation. Once expanded the stent must maintain its size and shape and must be capable of withstanding the structural loads, namely radial compressive forces, imposed on the stent as it supports the walls of a vessel lumen. The wall of the prosthesis must be sufficiently thick, depending on the stent material, not only to withstand the vessel wall recoil but also allow the stent to be seen on the fluoroscope. Finally, the prosthesis material must be biocompatible so as not to trigger any adverse vascular responses like restenosis or thrombus formation in the treated vessel.
- For medical devices such as all kind of catheters and guide wires special mechanical properties are desired to have perfect trackability and pushability during the intervention. Moreover, good radio-opacity and MRI compatibility are essential in order to survey medical procedures via x-ray and MRI. Finally also for these medical devices biocompatibility is a must.
- In the past years increased effort was undertaken to find new materials for medical implants and devices bearing superior characteristics over commonly used metals like stainless steel or titanium. Numerous publications focus on titanium alloys aiming at corrosion resistant, high strength and biocompatible alloys. As described for example in U.S. Pat. No. 6,312,455, U.S. 2001/0007953, and WO 99/58184 many Titanium-alloys thereof are super-elastic or shape memory alloys. A pseudo-elastic β-titanium alloy fabricated from Titanium, Molybdenum, Aluminium and optionally Niobium, Chrome and Vanadium is described in U.S. Pat. No. 6,258,182. EP 0 788 802 provides a self-expanding stent consisting of a titanium alloy including at least about 68 weight percent titanium and optionally Niobium, Zirconium, and Molybdenum. U.S. Pat. No. 6,238,491 and WO 00/68448 describe a Niobium-Titanium-Zirconium-Molybdenum alloy for medical devices providing a uniform β-structure, which is corrosion resistant, and can be processes to develop high-strength and low-modulus. The alloy comprises 29 to 70 weight percent Niobium, 10 to 46 weight percent Zirconium, 3 to 15 weight percent Molybdenum and a balance of Titanium. In another approach Davidson (EP 0 601 804) employ an alloy consisting essentially of Titanium, 10 to 20 or 25 to 50 weight percent Niobium and optionally up to 20 weight percent Zirconium, the alloy having an elastic modulus less than 90 GPa. Similar Titanium-alloys for medical implants also published by Davidson comprise Titanium, 10 to 20 or 35 to 50 weight percent Niobium and optionally up to 20 weight percent each Zirconium and Tantalum (EP 0 437 079) or Titanium, 10 to 20 or 35 to 50 weight percent each Niobium and Tantalum and optionally up to 20 weight percent Zirconium (U.S. Pat. No. 5,690,670). EP 0 707 085 also provides a low modulus, biocompatible Titanium-base alloy for medical devices consisting of 20 to 40 weight percent
- Niobium, 4,5 to 25 weight percent Tantalum, 2,5 to 13 weight percent Zirconium and the balance Titanium. A further high strength, low modulus and biocompatible Titanium-alloy is laid open in U.S. Pat. No. 4,857,269 and EP 0 359 446 consisting of Titanium and up to 25 weight percent Niobium, Zirconium, and Molybdenum. EP 1 046 722 describes a corrosion resistant Titanium-Zirconium-type alloy for medical appliances consisting of 25 to 50 weight percent Titanium, 5 to 30 weight percent Niobium, 5 to 40 weight percent Tantalum and 25 to 60 weight percent Zirconium.
- It is an object of the present invention to provide medical implants or devices, especially stents which have favourable mechanical properties, excellent biocompatibility, good radio-opacity while at the same time exhibiting minor image artefact in MRI examination (MRI compatibility) and does therefore overcome the drawbacks of recently available metals for medical purposes.
- The material should fulfil all mechanical and structural requirements according to its function in a medical implant or device. Moreover, the material should be sufficiently radio-opaque to allow for good imaging of the device under x-ray without the addition of an extra layer or portion of radio-opaque material. Also, the material should not overly bright in X-ray imaging and should not obscure the image of the surrounding tissue, as would be the case with a device made from an extremely dense material. In addition, the material should be MRI safe and compatible, preferably also visible under MRI.
- Surprisingly, it has been found that the desired properties can be given to a metal alloy essentially consisting of niobium and 0.85 to 1.15% of zirconium.
- The radio-opacity of the presently claimed Nb-Zr alloy is sufficient to be readily visualized under x-ray during medical procedures and yet is not so radio-opaque as to interfere with the visualization of surrounding body tissue.
- The material is generally an alloy of about 99% of Zr, rest Nb (Nb-1% Zr or NbZr1)—known for long as a reactor tubing material and for various other applications. It can easily be obtained in sheet or tube form. It is especially suitable for stents which require delicate and complicated patterns to be cut from the sheet or tube. The cutting is usually done by laser methods. Stents with low wall thickness may conveniently be manufactured.
- The alloy of the invention can be easily cold-worked to increase strength and reduce elastic modulus. It is possible to form a hard, abrasion resistant surface on the inventive alloy through standard oxidation and nitridizing methods known by those skilled in the art. The presence of a hard, inert, abrasion resistant surface layer presents an important option for medical implants and devices in which it is desirable to have lower friction and wear, electrical insulation and improved corrosion resistance.
- To further improve the biocompatibility of the medical implant or device fabricated at least in part from the inventive alloy, at least a portion of the surface of the inventive alloy can be conversion surface hardened and/or coated. Such coatings can include, but are not limited to a polymer, a blend of polymers, a metal, a blend of metals, a ceramic and/or biomolecules, in particular peptides, proteins, lipids, carbohydrates and/or nucleic acids (e.g. collagen, heparin, fibrin, phosphorylcholine, cellulose, morphogenic proteins or peptides, growth factors). Furthermore the alloy surface or the coatings can comprise stem cells and/or a bioactive substances, in particular drugs, antibiotics, growth factors, anti-inflammatory agents and/or anti-thrombogenic agents. Further, the surface can be modified by electropolishing or mechanical polishing for formation of a completely smooth surface, sintering to achieve a porous coating as for example described in EP0601804, or by roughening procedures or microblasting, in particular sandblasting, to achieve a rough surface.
- The Nb-Zr alloy is useful in the manufacturing of a variety of medical implants and devices. The manufacture of medical devices from the invention alloy includes minimal-invasive devices, in particular guide wires, catheters (balloon catheters, guiding catheter, angiographic catheters, functional catheters), intra-cavernous implants, in particular intra-oesophagus, intra-urethra, intra-tracheal implants and intra-vascular implants, in particular stents, stent grafts, stent graft connector, heart valve repair device or filters.
- The invention relates to medical implants or devices fabricated from the above-mentioned alloys, e.g. minimal-invasive devices, in particular catheters or guide wires, or intra-cavernous implants, in particular intravascular implants, such as stents, stent grafts, stent graft connectors or heart valve repair devices.
- In the above implants and devices the surface of the metal alloys may be passivated by oxidation or nitridization, or may be electropolished, mechanically polished, micro blasted, roughened or sintered, or may be coated with a polymer, a blend of polymers, a metal, a blend of metals, a ceramic and/or biomolecules, in particular peptides, proteins, lipids, carbohydrates and/or nucleic acids; or may be coated with stem cells and/or a bioactive substance, in particular drugs, antibiotics, growth factors, anti-inflammatory agents and/or anti-thrombogenic agents.
- A preferred material for the implants or devices of the invention is the following (All percentages are by weight): 98.85-99.15 weight percent Niobium and 0.85-1.15% Zirconium, preferably 99.05-99.15 weight percent Niobium, and 0.85-0.95% weight percent Zirconium. Especially preferred is the material: 99.05-99.15 weight percent Niobium and 0.85-0.95% weight percent Zirconium.
Claims (14)
1. A medical implant or device at least partially fabricated from a metal alloy consisting essentially of
(a) 98.85-99.15 weight percent Niobium,
(b) 0.85-1.15% weight percent Zirconium.
2. A medical implant or device according to claim 1 wherein said metal alloy consists essentially of
(a) 99.02-99.15 weight percent Niobium,
(b) 0.85-0.98% weight percent Zirconium.
3. A medical implant or device according to claim 1 wherein said metal alloy consists essentially of
(a) 99.05-99.15 weight percent Niobium,
(b) 0.85-0.95% weight percent Zirconium.
4. A medical device according to any one of claims 1 to 3 , wherein the medical device is a minimal-invasive device, in particular a catheter or a guide wire.
5. A medical implant or device according to any one of the claims 1 to 3 , wherein the medical implant is an intra-cavernous implant.
6. A medical implant or device according to claim 5 , wherein the medical implant is an intravascular implant.
7. A medical implant according to claim 6 , wherein the medical implant is a stent, a stent graft, a stent graft connector or a heart valve repair device.
8. A stent according to claim 7 which is composed of a single homogeneous, substantially non-decomposing tubing made from the metal alloy according of claim 1 .
9. A stent according to claim 8 which is composed of a single homogeneous substantially non-decomposing sheet made from the metal alloy according of claim 1 .
10. A medical implant or device according to any one of claims 1-3, wherein the surface of the metal alloy is passivated by oxidation or nitridization.
11. A medical implant or device according to any one of claims 1-3, wherein the surface of the metal alloy is coated with iridium oxide by vapor deposition.
12. A medical implant or device according to any one of claims 1-3, wherein the surface of the metal alloy is electropolished, mechanically polished, micro blasted, roughened or sintered.
13. A medical implant or device according to any one of claims 1-3, wherein the surface of the metal alloy is coated with a polymer, a blend of polymers, a metal, a blend of metals, a ceramic and/or biomolecules, in particular peptides, proteins, lipids, carbohydrates and/or nucleic acids.
14. A medical implant or device according to any one of claims 1-3, wherein the surface of the metal alloy is coated with stem cells and/or a bioactive substance, in particular drugs, antibiotics, growth factors, anti-inflammatory agents and/or anti-thrombogenic agents.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/705,566 US20050098241A1 (en) | 2003-11-11 | 2003-11-11 | Niobium-Zirconium Alloy for medical devices or their parts |
PCT/EP2004/012343 WO2005044327A1 (en) | 2003-11-11 | 2004-11-01 | Niobium-zirconium alloy for medical devices or their parts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/705,566 US20050098241A1 (en) | 2003-11-11 | 2003-11-11 | Niobium-Zirconium Alloy for medical devices or their parts |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050098241A1 true US20050098241A1 (en) | 2005-05-12 |
Family
ID=34552396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/705,566 Abandoned US20050098241A1 (en) | 2003-11-11 | 2003-11-11 | Niobium-Zirconium Alloy for medical devices or their parts |
Country Status (2)
Country | Link |
---|---|
US (1) | US20050098241A1 (en) |
WO (1) | WO2005044327A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060204535A1 (en) * | 2005-02-25 | 2006-09-14 | Johnson Johnnie M | Cell-friendly cannula and needle |
US20070250158A1 (en) * | 2006-04-25 | 2007-10-25 | Medtronic Vascular, Inc. | Laminated Implantable Medical Device Having a Metallic Coating |
US20080195194A1 (en) * | 2007-02-13 | 2008-08-14 | Abbott Cardiovascular Systems Inc. | Mri compatible, radiopaque alloys for use in medical devices |
US20080206441A1 (en) * | 2007-02-27 | 2008-08-28 | Medtronic Vascular, Inc. | Ion Beam Etching a Surface of an Implantable Medical Device |
US20090209944A1 (en) * | 2008-02-14 | 2009-08-20 | Cook Incorporated | Component of an implantable medical device comprising an oxide dispersion strengthened (ods) metal alloy |
US7691400B2 (en) | 2006-05-05 | 2010-04-06 | Medtronic Vascular, Inc. | Medical device having coating with zeolite drug reservoirs |
US20110200738A1 (en) * | 2007-03-28 | 2011-08-18 | Brian Pederson | System and Method for Conditioning Implantable Medical Devices |
US20170224884A1 (en) * | 2007-03-28 | 2017-08-10 | Medtronic ATS Medical, Inc. | Method for inhibiting platelet interaction with biomaterial surfaces |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5498302A (en) * | 1992-02-07 | 1996-03-12 | Smith & Nephew Richards, Inc. | Surface hardened biocompatible metallic medical implants |
US5931867A (en) * | 1997-04-25 | 1999-08-03 | W.C. Heraeus Gmbh | Radially expandable support device |
US6387121B1 (en) * | 1996-10-21 | 2002-05-14 | Inflow Dynamics Inc. | Vascular and endoluminal stents with improved coatings |
US6478815B1 (en) * | 2000-09-18 | 2002-11-12 | Inflow Dynamics Inc. | Vascular and endoluminal stents |
US6767360B1 (en) * | 2001-02-08 | 2004-07-27 | Inflow Dynamics Inc. | Vascular stent with composite structure for magnetic reasonance imaging capabilities |
US6790228B2 (en) * | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US6845259B2 (en) * | 2001-12-26 | 2005-01-18 | Advanced Cardiovascular Systems, Inc. | MRI compatible guide wire |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7101391B2 (en) * | 2000-09-18 | 2006-09-05 | Inflow Dynamics Inc. | Primarily niobium stent |
AU2001218611A1 (en) * | 2000-11-28 | 2002-06-11 | Fortimedix B.V. | Stent |
DE10245516B4 (en) * | 2002-09-27 | 2004-09-30 | W. C. Heraeus Gmbh & Co. Kg | Alloy for use with stents |
PT1444993E (en) * | 2003-02-10 | 2007-01-31 | Heraeus Gmbh W C | Improved metal alloy for medical devices and implants |
-
2003
- 2003-11-11 US US10/705,566 patent/US20050098241A1/en not_active Abandoned
-
2004
- 2004-11-01 WO PCT/EP2004/012343 patent/WO2005044327A1/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5498302A (en) * | 1992-02-07 | 1996-03-12 | Smith & Nephew Richards, Inc. | Surface hardened biocompatible metallic medical implants |
US6387121B1 (en) * | 1996-10-21 | 2002-05-14 | Inflow Dynamics Inc. | Vascular and endoluminal stents with improved coatings |
US5931867A (en) * | 1997-04-25 | 1999-08-03 | W.C. Heraeus Gmbh | Radially expandable support device |
US6790228B2 (en) * | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US6478815B1 (en) * | 2000-09-18 | 2002-11-12 | Inflow Dynamics Inc. | Vascular and endoluminal stents |
US6767360B1 (en) * | 2001-02-08 | 2004-07-27 | Inflow Dynamics Inc. | Vascular stent with composite structure for magnetic reasonance imaging capabilities |
US6845259B2 (en) * | 2001-12-26 | 2005-01-18 | Advanced Cardiovascular Systems, Inc. | MRI compatible guide wire |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060204535A1 (en) * | 2005-02-25 | 2006-09-14 | Johnson Johnnie M | Cell-friendly cannula and needle |
WO2007098289A3 (en) * | 2006-02-27 | 2008-07-10 | Tulip Biomed Inc | Cell-friendly cannula and needle |
US20070250158A1 (en) * | 2006-04-25 | 2007-10-25 | Medtronic Vascular, Inc. | Laminated Implantable Medical Device Having a Metallic Coating |
US7955383B2 (en) | 2006-04-25 | 2011-06-07 | Medtronics Vascular, Inc. | Laminated implantable medical device having a metallic coating |
US7691400B2 (en) | 2006-05-05 | 2010-04-06 | Medtronic Vascular, Inc. | Medical device having coating with zeolite drug reservoirs |
WO2008100852A3 (en) * | 2007-02-13 | 2009-12-03 | Abbott Cardiovascular Systems Inc. | Mri compatible, radiopaque alloys for use in medical devices |
US20080195194A1 (en) * | 2007-02-13 | 2008-08-14 | Abbott Cardiovascular Systems Inc. | Mri compatible, radiopaque alloys for use in medical devices |
US20080206441A1 (en) * | 2007-02-27 | 2008-08-28 | Medtronic Vascular, Inc. | Ion Beam Etching a Surface of an Implantable Medical Device |
US20110200738A1 (en) * | 2007-03-28 | 2011-08-18 | Brian Pederson | System and Method for Conditioning Implantable Medical Devices |
US8653632B2 (en) * | 2007-03-28 | 2014-02-18 | Medtronic Ats Medical Inc. | System and method for conditioning implantable medical devices |
US20170224884A1 (en) * | 2007-03-28 | 2017-08-10 | Medtronic ATS Medical, Inc. | Method for inhibiting platelet interaction with biomaterial surfaces |
US11020515B2 (en) * | 2007-03-28 | 2021-06-01 | Medtronic ATS Medical, Inc. | Method for inhibiting platelet interaction with biomaterial surfaces |
US11850335B2 (en) | 2007-03-28 | 2023-12-26 | Medtronic ATS Medical, Inc. | Method for inhibiting platelet interaction with biomaterial surfaces |
US20090209944A1 (en) * | 2008-02-14 | 2009-08-20 | Cook Incorporated | Component of an implantable medical device comprising an oxide dispersion strengthened (ods) metal alloy |
Also Published As
Publication number | Publication date |
---|---|
WO2005044327A1 (en) | 2005-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8349249B2 (en) | Metal alloy for medical devices and implants | |
US20080038146A1 (en) | Metal alloy for medical devices and implants | |
US20070276488A1 (en) | Medical implant or device | |
JP6290972B2 (en) | Endoprosthesis with multi-phase steel | |
US9649210B2 (en) | Hybrid stent and method of making | |
CN112584876B (en) | Iron-based biodegradable metals for implantable medical devices | |
JPH06233811A (en) | Medical transplantation piece consisting of titanium alloy which is organism compatible and of low modulus | |
WO2008033603A2 (en) | Medical devices having alloy compositions | |
US20120116499A1 (en) | Marker composite and medical implant comprising an x-ray marker | |
US9427500B2 (en) | Stent made of a cobalt alloy | |
Stanisławska | Biomaterials and implants in cardiac and vascular surgery-review | |
US20130338756A1 (en) | Stent composed of an iron alloy | |
US20050098241A1 (en) | Niobium-Zirconium Alloy for medical devices or their parts | |
US20120231048A1 (en) | Medical Devices and Implants from Nb-Ta-W-Zr Alloys | |
JP4137327B2 (en) | Medical device made of Ti-Zr alloy | |
Cui et al. | Biocompatibility and fabrication of in situ bioceramic coating | |
Tabish et al. | Biocompatibility behavior and biomedical applications of Ti-Ni based shape memory alloys: A brief review | |
JP2022049329A (en) | Medical composite material | |
HK1170424B (en) | Endoprosthesis containing multi-phase ferrous steel | |
HK1170424A (en) | Endoprosthesis containing multi-phase ferrous steel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: W.C. HERAEUS GMBH & CO., KG, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WACHTER, HANS-JURGEN;TROTZSCHEL, JENS;FRERICKS, MATTHIAS;REEL/FRAME:014417/0985;SIGNING DATES FROM 20040303 TO 20040305 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: HERAEUS PRECIOUS METALS GMBH & CO. KG, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:W.C. HERAEUS GMBH & CO. KG;REEL/FRAME:032973/0477 Effective date: 20110801 |